Key result
Elevated miR-183-5p is linked to atherosclerosis and promotes VSMC proliferation and migration.
Why the study?
Atherosclerosis is a multifactorial chronic disease involving vascular smooth muscle cells, and the clinical value of miR-183-5p in AS patients and its effects on VSMCs were unclear.
Does miR-183-5p serve as a diagnostic biomarker for atherosclerosis and regulate vascular smooth muscle cell growth?
Case-Control
Does miR-183-5p serve as a diagnostic biomarker for atherosclerosis and regulate vascular smooth muscle cell growth?
Answers are grounded in this paper and cite their sources.
MiR-183-5p is upregulated in atherosclerosis, correlates with disease markers, and promotes vascular smooth muscle cell proliferation and migration, suggesting potential as a diagnostic biomarker.
BACKGROUND: Atherosclerosis (AS) is a multifactorial chronic disease, and vascular smooth muscle cells (VSMCs) play important roles in the pathology of AS. Micro-RNAs regulate multiple cellular biological processes. This study aimed to investigate the clinical value of miR-183-5p in AS patients and further explored the effects of miR-183-5p on the proliferation and migration of VSMCs. METHODS: Quantitative real-time polymerase chain reaction was used to test the level of miR-183-5p. The diagnostic value of miR-183-5p for AS patients was assessed by a receiver operating characteristic (ROC) analysis. The proliferation and migration of VSMCs were determined via the CCK-8 and Transwell assay. RESULTS: MiR-183-5p was highly expressed in AS patients compared with the healthy group. Serum miR-183-5p expression was positively associated with carotid intima-media thickness and C-reactive protein in AS patients. The ROC analysis suggested that miR-183-5p had the quality to be used as a biomarker with high specificity and sensitivity for AS detection. Overexpression of miR-183-5p promoted the proliferation and migration of VSMCs. CONCLUSION: MiR-183-5p is highly expressed in AS patients, which promotes the proliferation and migration of VSMCs. MiR-183-5p may be a key molecular in the diagnosis and treatment of AS in the future.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2020) conducted a case-control in Atherosclerosis. miR-183-5p vs. Healthy group was evaluated on Atherosclerosis detection. MiR-183-5p was highly expressed in atherosclerosis patients compared with healthy controls, demonstrating potential as a diagnostic biomarker and promoting VSMC proliferation and migration.
Synapse has enriched 10 related papers. Consider them for comparative context: